Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › mycosis fungoides

Mycosis fungoides

Part of Non-Hodgkin's Lymphoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for mycosis fungoides

11 trials tracked for mycosis fungoides: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 579 citations.

11Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 7 Phase 1 2 Other / NA 1
  1. Phase 3 A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) Completed · 579 cited
  2. Phase 2 Mechlorethamine Induced Contact Dermatitis Avoidance Study Completed
  3. Phase 2 CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas Completed
  4. Phase 2 Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome Completed
  5. Phase 2 Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level Completed
  6. Phase 2 Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL Completed
Show 5 more trials
  1. Phase 2 Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides Completed
  2. Phase 2 Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides Completed
  3. Phase 1 Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies Completed
  4. Phase 1 Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome Completed
  5. N/A Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
CXCL13 quantification in PBMCs and plasma distinguishes Sézary syndrome from other cutaneous T-cell lymphomas and dermatoses
Allergy & Immunology Cohort
CXCL13 quantification in PBMCs and plasma distinguishes Sézary syndrome from other cutaneous T-cell lymphomas and dermatoses A simple blood test could spot a rare skin cancer faster
This cohort study analyzed CXCL13 expression in peripheral blood mononuclear cells (PBMCs) and plasma concentrations in patients with suspec…
A simple blood test for a protein called CXCL13 may help doctors catch a rare, aggressive skin cancer that often looks like eczema for years…
Frontiers Apr 13, 2026